Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Chiroscience

Chiroscience?uq=UG6efJS6
1992 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$1.12B LATEST DEAL AMOUNT
Description

Developer of pharmaceutical products through chiral technology. The company provides biocatalysis to make chiral molecules for new drugs. It also supplies chiral intermediates to the drug industry.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Celltech Chiroscience
Primary Office
  • 283 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WE
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Chiroscience’s full profile, request a free trial.

Chiroscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 16-Jun-1999 $1.12B 000.00 00.000 Completed Generating Revenue
3. IPO 01-Feb-1994 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 01-Jun-1993 $5M Completed Startup
1. Early Stage VC 01-Mar-1992 $5M $5M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Chiroscience Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3i VC-Backed Company Minority 000 0000 000000 0
Apax Partners PE/Buyout Minority 000 0000 000000 0
CHL Medical Partners Venture Capital Minority 000 0000 000000 0
Excalibur Group Holdings Venture Capital Minority 000 0000 000000 0
Permira PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »